Diabetes and stem cells

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The existence of clinically successful cell therapies (islet transplantation) for type 1 diabetes has stoked a keen interest in developing alternative, inexhaustible sources of insulin-producing cells. In this chapter we will broadly cover the state of the art regenerative therapies for the endocrine component of the pancreas, from stem cells to transdifferentiation. In particular, we will review the basics of pancreatic development, whose recapitulation remains the subject of a plethora of in vitro differentiation strategies using both embryonic and adult stem cells. Then we will examine the leading theories about the cellular and molecular mechanisms behind the in vivo regeneration of the organ that is observed under specific circumstances, as well as the purported ability of some tissues to turn into pancreatic endocrine cells when subjected to specific interventions (transdifferentiation). Finally, we will conclude with a general overview of the remaining challenges and clinical perspectives of all the above strategies, with a special emphasis on the immunological hurdles to be overcome for these approaches to find their way to standard clinical practice.

Original languageEnglish
Title of host publicationStem Cell and Regenerative Medicine
PublisherBentham Science Publishers Ltd.
Pages120-139
Number of pages20
ISBN (Print)9781608056972
DOIs
StatePublished - Dec 1 2010

Fingerprint

Cell Transdifferentiation
Art Therapy
Islets of Langerhans Transplantation
Adult Stem Cells
Aptitude
Endocrine Cells
Embryonic Stem Cells
Cell- and Tissue-Based Therapy
Type 1 Diabetes Mellitus
Islets of Langerhans
Regeneration
Stem Cells
Insulin
In Vitro Techniques

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Dominguez-Bendala, J., & Ricordi, C. (2010). Diabetes and stem cells. In Stem Cell and Regenerative Medicine (pp. 120-139). Bentham Science Publishers Ltd.. https://doi.org/10.2174/978160805008611001010120

Diabetes and stem cells. / Dominguez-Bendala, Juan; Ricordi, Camillo.

Stem Cell and Regenerative Medicine. Bentham Science Publishers Ltd., 2010. p. 120-139.

Research output: Chapter in Book/Report/Conference proceedingChapter

Dominguez-Bendala, J & Ricordi, C 2010, Diabetes and stem cells. in Stem Cell and Regenerative Medicine. Bentham Science Publishers Ltd., pp. 120-139. https://doi.org/10.2174/978160805008611001010120
Dominguez-Bendala J, Ricordi C. Diabetes and stem cells. In Stem Cell and Regenerative Medicine. Bentham Science Publishers Ltd. 2010. p. 120-139 https://doi.org/10.2174/978160805008611001010120
Dominguez-Bendala, Juan ; Ricordi, Camillo. / Diabetes and stem cells. Stem Cell and Regenerative Medicine. Bentham Science Publishers Ltd., 2010. pp. 120-139
@inbook{78bcb8bb0fff46e8a30bc89ac5ef1c12,
title = "Diabetes and stem cells",
abstract = "The existence of clinically successful cell therapies (islet transplantation) for type 1 diabetes has stoked a keen interest in developing alternative, inexhaustible sources of insulin-producing cells. In this chapter we will broadly cover the state of the art regenerative therapies for the endocrine component of the pancreas, from stem cells to transdifferentiation. In particular, we will review the basics of pancreatic development, whose recapitulation remains the subject of a plethora of in vitro differentiation strategies using both embryonic and adult stem cells. Then we will examine the leading theories about the cellular and molecular mechanisms behind the in vivo regeneration of the organ that is observed under specific circumstances, as well as the purported ability of some tissues to turn into pancreatic endocrine cells when subjected to specific interventions (transdifferentiation). Finally, we will conclude with a general overview of the remaining challenges and clinical perspectives of all the above strategies, with a special emphasis on the immunological hurdles to be overcome for these approaches to find their way to standard clinical practice.",
author = "Juan Dominguez-Bendala and Camillo Ricordi",
year = "2010",
month = "12",
day = "1",
doi = "10.2174/978160805008611001010120",
language = "English",
isbn = "9781608056972",
pages = "120--139",
booktitle = "Stem Cell and Regenerative Medicine",
publisher = "Bentham Science Publishers Ltd.",

}

TY - CHAP

T1 - Diabetes and stem cells

AU - Dominguez-Bendala, Juan

AU - Ricordi, Camillo

PY - 2010/12/1

Y1 - 2010/12/1

N2 - The existence of clinically successful cell therapies (islet transplantation) for type 1 diabetes has stoked a keen interest in developing alternative, inexhaustible sources of insulin-producing cells. In this chapter we will broadly cover the state of the art regenerative therapies for the endocrine component of the pancreas, from stem cells to transdifferentiation. In particular, we will review the basics of pancreatic development, whose recapitulation remains the subject of a plethora of in vitro differentiation strategies using both embryonic and adult stem cells. Then we will examine the leading theories about the cellular and molecular mechanisms behind the in vivo regeneration of the organ that is observed under specific circumstances, as well as the purported ability of some tissues to turn into pancreatic endocrine cells when subjected to specific interventions (transdifferentiation). Finally, we will conclude with a general overview of the remaining challenges and clinical perspectives of all the above strategies, with a special emphasis on the immunological hurdles to be overcome for these approaches to find their way to standard clinical practice.

AB - The existence of clinically successful cell therapies (islet transplantation) for type 1 diabetes has stoked a keen interest in developing alternative, inexhaustible sources of insulin-producing cells. In this chapter we will broadly cover the state of the art regenerative therapies for the endocrine component of the pancreas, from stem cells to transdifferentiation. In particular, we will review the basics of pancreatic development, whose recapitulation remains the subject of a plethora of in vitro differentiation strategies using both embryonic and adult stem cells. Then we will examine the leading theories about the cellular and molecular mechanisms behind the in vivo regeneration of the organ that is observed under specific circumstances, as well as the purported ability of some tissues to turn into pancreatic endocrine cells when subjected to specific interventions (transdifferentiation). Finally, we will conclude with a general overview of the remaining challenges and clinical perspectives of all the above strategies, with a special emphasis on the immunological hurdles to be overcome for these approaches to find their way to standard clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=84882643325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882643325&partnerID=8YFLogxK

U2 - 10.2174/978160805008611001010120

DO - 10.2174/978160805008611001010120

M3 - Chapter

AN - SCOPUS:84882643325

SN - 9781608056972

SP - 120

EP - 139

BT - Stem Cell and Regenerative Medicine

PB - Bentham Science Publishers Ltd.

ER -